Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1324
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Heron Therapeutics Inc (HRTX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Heron Therapeutics Inc (Heron), formerly A.P. Pharma Inc, is a biotechnology company that uses proprietary polymer-based drug delivery platform to develop novel, patient-focused drugs for patients suffering from cancer and pain. Its proprietary Biochronomer technology is a polymer-based drug delivery platform, which improves the therapeutic profile of injectable pharmaceuticals. The company’s first commercial product, Sustol is an extended-release injection indicated in combination with other antiemetics in adults for the prevention of nausea and vomiting due to moderately emetogenic chemotherapy (MEC) or anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. Heron’s developmental pipeline includes HTX-011 for post-operative pain management and Cinvanti for chemotherapy-induced nausea and vomiting (CINV) prevention. Heron is headquartered in San Diego, California, the US.

Heron Therapeutics Inc Key Recent Developments

Mar 02,2020: Heron Therapeutics announces financial results for the three and twelve months ended december 31, 2019 and highlights recent corporate updates
Feb 18,2020: Heron Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Jan 13,2020: Heron Therapeutics highlights progress in pain management and CINV franchises
Nov 12,2019: Heron Therapeutics announces financial results for the three and nine months ended september 30, 2019 and highlights recent corporate updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Heron Therapeutics Inc – Key Facts
Heron Therapeutics Inc – Key Employees
Heron Therapeutics Inc – Key Employee Biographies
Heron Therapeutics Inc – Major Products and Services
Heron Therapeutics Inc – History
Heron Therapeutics Inc – Company Statement
Heron Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Heron Therapeutics Inc – Business Description
Product Category: Cinvanti
Overview
Performance
Product Category: HTX-011
Overview
Product Category: HTX-034
Overview
Product Category: Sustol
Overview
Performance
R&D Overview
Heron Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Heron Therapeutics Inc – Strengths
Heron Therapeutics Inc – Weaknesses
Heron Therapeutics Inc – Opportunities
Heron Therapeutics Inc – Threats
Heron Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Heron Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 02, 2020: Heron Therapeutics announces financial results for the three and twelve months ended december 31, 2019 and highlights recent corporate updates
Jan 13, 2020: Heron Therapeutics highlights progress in pain management and CINV franchises
Nov 12, 2019: Heron Therapeutics announces financial results for the three and nine months ended september 30, 2019 and highlights recent corporate updates
Oct 01, 2019: Heron Therapeutics appoints Stephen Davis to Board of Directors
Oct 01, 2019: Heron Therapeutics appoints Kimberly Manhard to Board of Directors
Aug 05, 2019: Heron Therapeutics announces financial results for the Three and Six Months Ended June 30, 2019 and highlights recent corporate updates
May 09, 2019: Heron Therapeutics announces financial results for the three months ended March 31, 2019 and highlights recent corporate progress
Feb 22, 2019: Heron Therapeutics announces financial results for the three and twelve months ended December 31, 2018 and recent corporate progress
Feb 05, 2019: Heron Therapeutics announces Retirement of Robert Rosen as President
Jan 07, 2019: Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Heron Therapeutics Inc, Key Facts
Heron Therapeutics Inc, Key Employees
Heron Therapeutics Inc, Key Employee Biographies
Heron Therapeutics Inc, Major Products and Services
Heron Therapeutics Inc, History
Heron Therapeutics Inc, Other Locations
Heron Therapeutics Inc, Key Competitors
Heron Therapeutics Inc, Ratios based on current share price
Heron Therapeutics Inc, Annual Ratios
Heron Therapeutics Inc, Annual Ratios (Cont...1)
Heron Therapeutics Inc, Interim Ratios
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Heron Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Heron Therapeutics Inc, Performance Chart (2015 - 2019)
Heron Therapeutics Inc, Ratio Charts
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Heron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Bruker Daltonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bruker Daltonics Inc (Bruker Daltonics), a subsidiary of Bruker Corp, is a medical device company that manufactures scientific instruments for molecular and materials research, and for industrial and applied analysis. The company's products include mass spectrometry and separations, preclini …
  • Oxtex Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oxtex Ltd (Oxtex), formerly Oxtexs Ltd is a medical device company that offers novel self inflating tissue expansion and medical devices. The company’s products include implantable self-inflating tissue expanders that are suitable for specific needs of the clinician and the patient. It uses …
  • OK Biotech Co Ltd (4155):医療機器:M&Aディール及び事業提携情報
    Summary OK Biotech Co Ltd (OK Biotech) is a medical device manufacturing and distribution company that manufactures and distributes blood glucose monitoring devices and homecare medical products, among others. The company’s blood glucose monitoring devices include blood glucose meter systems, blood …
  • Nissin Foods Holdings Co Ltd (2897):企業の財務・戦略的SWOT分析
    Nissin Foods Holdings Co Ltd (2897) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Saipem SpA:企業の戦略・SWOT・財務分析
    Saipem SpA - Strategy, SWOT and Corporate Finance Report Summary Saipem SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Canada Life Financial Corporation:企業の戦略的SWOT分析
    Canada Life Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Trex Company Inc (TREX):企業の財務・戦略的SWOT分析
    Trex Company Inc (TREX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務分析
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • ITC Ltd:戦略・SWOT・企業財務分析
    ITC Ltd - Strategy, SWOT and Corporate Finance Report Summary ITC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization that provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinica …
  • ACWA Power Barka SAOG (APBS):企業の財務・戦略的SWOT分析
    ACWA Power Barka SAOG (APBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Country Club Hospitality & Holidays Ltd.:企業の戦略・SWOT・財務分析
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • OMEICOS Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary OMEICOS Therapeutics GmbH (OMEICOS) is a biopharmaceutical company that develops small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases. The company utilizes its proprietary technology of the body’s own omega-3 fatty acid metabolic processes to …
  • PlantForm Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PlantForm Corp (PlantForm) is a biopharmaceutical company that develops and produces specialty antibody and protein drugs. The company’s pipeline products include biosimilar ranibizumab, trastuzumab, hD9 antibody for ricin exposure, recombinant butyrylcholinesterase, antibodies for HIV or AI …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Expedia Inc:企業のM&A・事業提携・投資動向
    Expedia Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Expedia Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • China National Biotec Group-製薬・医療分野:企業M&A・提携分析
    Summary China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corp is a manufacturer and distributor of vaccines, therapeutic products and diagnostic reagents. The company develops biological products for disease prevention, therapeutic and diagnostic use. Its produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆